68 results on '"Pirouzmand F."'
Search Results
2. Molecular and translational advances in meningiomas
- Author
-
Suppiah S., Nassiri F., Bi W. L., Dunn I. F., Hanemann C. O., Horbinski C. M., Hashizume R., James C. D., Mawrin C., Noushmehr H., Perry A., Sahm F., Sloan A., Von Deimling A., Wen P. Y., Aldape K., Zadeh G., Au K., Barnhartz-Sloan J., Brastianos P. K., Butowski N., Carlotti C., Cusimano M. D., Dimeco F., Drummond K., Galanis E., Giannini C., Goldbrunner R., Griffith B., Herold-Mende C., Huang R. Y., James D., Jenkinson M. D., Jungk C., Kaufman T. J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J. C., Mamatjan Y., Mansouri A., McDermott M., Munoz D., Ng H. -K., Pirouzmand F., Poisson L. M., Pollo B., Raleigh D., Saladino A., Santarius T., Schichor C., Schultz D., Schmidt N. O., Selman W., Spears J., Snyder J., Tabatabai G., Tatagiba M., Tirapelli D., Tonn J. C., Tsang D., Vogelbaum M. A., Deimling A. V., Walbert T., Westphal M., Workewych A. M., Suppiah S., Nassiri F., Bi W.L., Dunn I.F., Hanemann C.O., Horbinski C.M., Hashizume R., James C.D., Mawrin C., Noushmehr H., Perry A., Sahm F., Sloan A., Von Deimling A., Wen P.Y., Aldape K., Zadeh G., Au K., Barnhartz-Sloan J., Brastianos P.K., Butowski N., Carlotti C., Cusimano M.D., Dimeco F., Drummond K., Galanis E., Giannini C., Goldbrunner R., Griffith B., Herold-Mende C., Huang R.Y., James D., Jenkinson M.D., Jungk C., Kaufman T.J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J.C., Mamatjan Y., Mansouri A., McDermott M., Munoz D., Ng H.-K., Pirouzmand F., Poisson L.M., Pollo B., Raleigh D., Saladino A., Santarius T., Schichor C., Schultz D., Schmidt N.O., Selman W., Spears J., Snyder J., Tabatabai G., Tatagiba M., Tirapelli D., Tonn J.C., Tsang D., Vogelbaum M.A., Deimling A.V., Walbert T., Westphal M., and Workewych A.M.
- Subjects
Cancer Research ,Supplement Articles ,Genomics ,Intracranial Neoplasm ,sporadic meningioma ,Bioinformatics ,World health ,Translational Research, Biomedical ,Meningioma ,03 medical and health sciences ,biomolecular ,0302 clinical medicine ,Meningeal Neoplasms ,otorhinolaryngologic diseases ,medicine ,Recurrent disease ,Humans ,Meningeal Neoplasm ,Molecular Targeted Therapy ,xenograft ,Stage (cooking) ,neoplasms ,MENINGIOMA ,business.industry ,cell line ,Prognosis ,medicine.disease ,Combined Modality Therapy ,nervous system diseases ,3. Good health ,Clinical trial ,Oncology ,030220 oncology & carcinogenesis ,Neurology (clinical) ,genetic ,business ,epigenetic ,030217 neurology & neurosurgery - Abstract
Meningiomas are the most common primary intracranial neoplasm. The current World Health Organization (WHO) classification categorizes meningiomas based on histopathological features, but emerging molecular data demonstrate the importance of genomic and epigenomic factors in the clinical behavior of these tumors. Treatment options for symptomatic meningiomas are limited to surgical resection where possible and adjuvant radiation therapy for tumors with concerning histopathological features or recurrent disease. At present, alternative adjuvant treatment options are not available in part due to limited historical biological analysis and clinical trial investigation on meningiomas. With advances in molecular and genomic techniques in the last decade, we have witnessed a surge of interest in understanding the genomic and epigenomic landscape of meningiomas. The field is now at the stage to adopt this molecular knowledge to refine meningioma classification and introduce molecular algorithms that can guide prediction and therapeutics for this tumor type. Animal models that recapitulate meningiomas faithfully are in critical need to test new therapeutics to facilitate rapid-cycle translation to clinical trials. Here we review the most up-to-date knowledge of molecular alterations that provide insight into meningioma behavior and are ready for application to clinical trial investigation, and highlight the landscape of available preclinical models in meningiomas.
- Published
- 2019
3. Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life
- Author
-
Nassiri F., Price B., Shehab A., Au K., Cusimano M. D., Jenkinson M. D., Jungk C., Mansouri A., Santarius T., Suppiah S., Teng K. X., Toor G. S., Zadeh G., Walbert T., Drummond K. J., Aldape K., Barnhartz-Sloan J., Bi W. L., Brastianos P. K., Butowski N., Carlotti C., Dimeco F., Dunn I. F., Galanis E., Giannini C., Goldbrunner R., Griffith B., Hashizume R., Hanemann C. O., Herold-Mende C., Horbinski C., Huang R. Y., James D., Kaufman T. J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J. C., Mamatjan Y., Mawrin C., McDermott M., Munoz D., Noushmehr H., Ng H. -K., Perry A., Pirouzmand F., Poisson L. M., Pollo B., Raleigh D., Sahm F., Saladino A., Schichor C., Schultz D., Schmidt N. O., Selman W., Sloan A., Spears J., Snyder J., Tabatabai G., Tatagiba M., Tirapelli D., Tonn J. C., Tsang D., Vogelbaum M. A., Deimling A. V., Wen P. Y., Westphal M., Workewych A. M., Nassiri F., Price B., Shehab A., Au K., Cusimano M.D., Jenkinson M.D., Jungk C., Mansouri A., Santarius T., Suppiah S., Teng K.X., Toor G.S., Zadeh G., Walbert T., Drummond K.J., Aldape K., Barnhartz-Sloan J., Bi W.L., Brastianos P.K., Butowski N., Carlotti C., Dimeco F., Dunn I.F., Galanis E., Giannini C., Goldbrunner R., Griffith B., Hashizume R., Hanemann C.O., Herold-Mende C., Horbinski C., Huang R.Y., James D., Kaufman T.J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J.C., Mamatjan Y., Mawrin C., McDermott M., Munoz D., Noushmehr H., Ng H.-K., Perry A., Pirouzmand F., Poisson L.M., Pollo B., Raleigh D., Sahm F., Saladino A., Schichor C., Schultz D., Schmidt N.O., Selman W., Sloan A., Spears J., Snyder J., Tabatabai G., Tatagiba M., Tirapelli D., Tonn J.C., Tsang D., Vogelbaum M.A., Deimling A.V., Wen P.Y., Westphal M., and Workewych A.M.
- Subjects
Male ,cognition ,Cancer Research ,medicine.medical_specialty ,Cross-sectional study ,insomnia ,Population ,Neurosurgery ,Supplement Articles ,meningioma ,surgery ,Meningioma ,03 medical and health sciences ,0302 clinical medicine ,Quality of life ,Surveys and Questionnaires ,Internal medicine ,Meningeal Neoplasms ,otorhinolaryngologic diseases ,medicine ,Humans ,Longitudinal Studies ,Prospective Studies ,Prospective cohort study ,education ,education.field_of_study ,business.industry ,COGNIÇÃO ,Cognition ,Middle Aged ,Prognosis ,medicine.disease ,humanities ,3. Good health ,health-related quality of life ,Cross-Sectional Studies ,Oncology ,030220 oncology & carcinogenesis ,Quality of Life ,Female ,fatigue ,Neurology (clinical) ,business ,030217 neurology & neurosurgery ,Follow-Up Studies ,Cohort study - Abstract
Background Few studies have evaluated the health-related quality of life (HRQoL) of patients with meningiomas. Here, we report the largest prospective, longitudinal cross-sectional cohort study of HRQoL in meningiomas to date, in order to identify possible actionable determinants of global HRQoL. Methods Adults who had undergone resection of a grade I intracranial meningioma and were in routine follow-up at a single large tertiary center underwent HRQoL assessment using the QLQ-C30 questionnaire administered opportunistically at follow-up visits. Averaged transformed QLQ-C30 scores at 12-month intervals were compared with scores from a normative reference population, with reference to known minimal clinically meaningful difference (CMD) in scores. To evaluate for possible determinants of changes in global HRQoL, global HRQoL scores were correlated (Spearman's Rho) with subdomain and symptom scores and with interval time from surgical resection. Results A total of 291 postoperative patients with histologically confirmed and surgically treated grade I meningiomas consented to participation and a total of 455 questionnaires were included for analysis. Patients with meningiomas reported reduced global HRQoL at nearly every 12-month interval with clinically and statistically significant impairments at 12, 48, 108, and 120 months postoperative compared with the normative population (P < 0.05). Meningioma patients at the 12-month interval also reported a reduction of each subdomain of HRQoL assessment (P < 0.05); however, a CMD was only seen in cognitive functioning. Physical, emotional, cognitive, and social subdomains, as well as fatigue and sleep/insomnia, were significantly associated with global HRQoL at the first 12-month interval. Overall, there was no significant correlation between time from surgery and global HRQoL or the subdomain functional or symptom sections of the QLQ-C30. Conclusions Meningioma patients report considerable limitations in HRQoL for more than 120 months after surgery, particularly in cognitive, emotional, and social function, as well as suffering significant fatigue and sleep impairment compared with a normative reference population. The majority of these reported functional impairments and symptoms are strongly associated with global HRQoL and thus can be considered determinants of global HRQoL that if treated, have the potential to improve HRQoL for our meningioma patients. This hypothesis requires future study of targeted interventions to determine their efficacy.
- Published
- 2019
4. Intraoperative cytodiagnosis of progressive multifocal leucoencephalopathy
- Author
-
Keith, J., Pirouzmand, F., Diamandis, P., and Ghorab, Z.
- Published
- 2014
- Full Text
- View/download PDF
5. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management
- Author
-
Nassiri F., Mamatjan Y., Suppiah S., Badhiwala J. H., Mansouri S., Karimi S., Saarela O., Poisson L., Gepfner-Tuma I., Schittenhelm J., Ng H. -K., Noushmehr H., Harter P., Baumgarten P., Weller M., Preusser M., Herold-Mende C., Tatagiba M., Tabatabai G., Sahm F., Von Deimling A., Aldape K., Au K., Barnhartz-Sloan J., Bi W. L., Brastianos P. K., Butowski N., Carlotti C., Cusimano M. D., Dimeco F., Drummond K., Dunn I. F., Galanis E., Giannini C., Goldbrunner R., Griffith B., Hashizume R., Hanemann C. O., Horbinski C., Huang R. Y., James D., Jenkinson M. D., Jungk C., Kaufman T. J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J. C., Malta T. M., Mawrin C., McDermott M., Munoz D., Perry A., Pirouzmand F., Poisson L. M., Pollo B., Raleigh D., Saladino A., Santarius T., Schichor C., Schultz D., Schmidt N. O., Selman W., Sloan A., Spears J., Snyder J., Tirapelli D., Tonn J. C., Tsang D., Vogelbaum M. A., Wen P. Y., Walbert T., Westphal M., Workewych A. M., Zadeh G., Aldape K. D., Nassiri F., Mamatjan Y., Suppiah S., Badhiwala J.H., Mansouri S., Karimi S., Saarela O., Poisson L., Gepfner-Tuma I., Schittenhelm J., Ng H.-K., Noushmehr H., Harter P., Baumgarten P., Weller M., Preusser M., Herold-Mende C., Tatagiba M., Tabatabai G., Sahm F., Von Deimling A., Aldape K., Au K., Barnhartz-Sloan J., Bi W.L., Brastianos P.K., Butowski N., Carlotti C., Cusimano M.D., Dimeco F., Drummond K., Dunn I.F., Galanis E., Giannini C., Goldbrunner R., Griffith B., Hashizume R., Hanemann C.O., Horbinski C., Huang R.Y., James D., Jenkinson M.D., Jungk C., Kaufman T.J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J.C., Malta T.M., Mawrin C., McDermott M., Munoz D., Perry A., Pirouzmand F., Poisson L.M., Pollo B., Raleigh D., Saladino A., Santarius T., Schichor C., Schultz D., Schmidt N.O., Selman W., Sloan A., Spears J., Snyder J., Tirapelli D., Tonn J.C., Tsang D., Vogelbaum M.A., Wen P.Y., Walbert T., Westphal M., Workewych A.M., Zadeh G., and Aldape K.D.
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,recurrence ,predictor ,ESTUDOS DE VALIDAÇÃO ,Meningioma ,nomogram ,Internal medicine ,medicine ,Biomarkers, Tumor ,Meningeal Neoplasms ,Humans ,Survival rate ,Retrospective Studies ,Oncotype DX Breast Cancer Assay ,business.industry ,Hazard ratio ,Cancer ,Disease Management ,Retrospective cohort study ,Nomogram ,DNA Methylation ,medicine.disease ,Prognosis ,Gene Expression Regulation, Neoplastic ,Survival Rate ,Clinical research ,Basic and Translational Investigations ,Neurology (clinical) ,methylation ,Neoplasm Recurrence, Local ,business ,Follow-Up Studies - Abstract
Background Variability in standard-of-care classifications precludes accurate predictions of early tumor recurrence for individual patients with meningioma, limiting the appropriate selection of patients who would benefit from adjuvant radiotherapy to delay recurrence. We aimed to develop an individualized prediction model of early recurrence risk combining clinical and molecular factors in meningioma. Methods DNA methylation profiles of clinically annotated tumor samples across multiple institutions were used to develop a methylome model of 5-year recurrence-free survival (RFS). Subsequently, a 5-year meningioma recurrence score was generated using a nomogram that integrated the methylome model with established prognostic clinical factors. Performance of both models was evaluated and compared with standard-of-care models using multiple independent cohorts. Results The methylome-based predictor of 5-year RFS performed favorably compared with a grade-based predictor when tested using the 3 validation cohorts (ΔAUC = 0.10, 95% CI: 0.03–0.018) and was independently associated with RFS after adjusting for histopathologic grade, extent of resection, and burden of copy number alterations (hazard ratio 3.6, 95% CI: 1.8–7.2, P < 0.001). A nomogram combining the methylome predictor with clinical factors demonstrated greater discrimination than a nomogram using clinical factors alone in 2 independent validation cohorts (ΔAUC = 0.25, 95% CI: 0.22–0.27) and resulted in 2 groups with distinct recurrence patterns (hazard ratio 7.7, 95% CI: 5.3–11.1, P < 0.001) with clinical implications. Conclusions The models developed and validated in this study provide important prognostic information not captured by previously established clinical and molecular factors which could be used to individualize decisions regarding postoperative therapeutic interventions, in particular whether to treat patients with adjuvant radiotherapy versus observation alone.
- Published
- 2019
6. Advances in multidisciplinary therapy for meningiomas
- Author
-
Brastianos P. K., Galanis E., Butowski N., Chan J. W., Dunn I. F., Goldbrunner R., Herold-Mende C., Ippen F. M., Mawrin C., McDermott M. W., Sloan A., Snyder J., Tabatabai G., Tatagiba M., Tonn J. C., Wen P. Y., Aldape K., Nassiri F., Zadeh G., Jenkinson M. D., Raleigh D. R., Au K., Barnhartz-Sloan J., Bi W. L., Carlotti C., Cusimano M. D., Dimeco F., Drummond K., Giannini C., Griffith B., Hashizume R., Hanemann C. O., Horbinski C., Huang R. Y., James D., Jungk C., Kaufman T. J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J. C., Mamatjan Y., Mansouri A., Munoz D., Noushmehr H., Ng H. -K., Perry A., Pirouzmand F., Poisson L. M., Pollo B., Sahm F., Saladino A., Santarius T., Schichor C., Schultz D., Schmidt N. O., Selman W., Spears J., Suppiah S., Tirapelli D., Tsang D., Vogelbaum M. A., Deimling A. V., Walbert T., Westphal M., Workewych A. M., Brastianos P.K., Galanis E., Butowski N., Chan J.W., Dunn I.F., Goldbrunner R., Herold-Mende C., Ippen F.M., Mawrin C., McDermott M.W., Sloan A., Snyder J., Tabatabai G., Tatagiba M., Tonn J.C., Wen P.Y., Aldape K., Nassiri F., Zadeh G., Jenkinson M.D., Raleigh D.R., Au K., Barnhartz-Sloan J., Bi W.L., Carlotti C., Cusimano M.D., Dimeco F., Drummond K., Giannini C., Griffith B., Hashizume R., Hanemann C.O., Horbinski C., Huang R.Y., James D., Jungk C., Kaufman T.J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J.C., Mamatjan Y., Mansouri A., Munoz D., Noushmehr H., Ng H.-K., Perry A., Pirouzmand F., Poisson L.M., Pollo B., Sahm F., Saladino A., Santarius T., Schichor C., Schultz D., Schmidt N.O., Selman W., Spears J., Suppiah S., Tirapelli D., Tsang D., Vogelbaum M.A., Deimling A.V., Walbert T., Westphal M., and Workewych A.M.
- Subjects
Oncology ,Cancer Research ,medicine.medical_treatment ,Supplement Articles ,meningioma ,Systemic therapy ,surgery ,0302 clinical medicine ,Meningeal Neoplasms ,Trabectedin ,Cancer ,clinical trial ,targeted therapy ,Prognosis ,Combined Modality Therapy ,3. Good health ,6.1 Pharmaceuticals ,030220 oncology & carcinogenesis ,International Consortium on Meningiomas ,Patient Safety ,Meningioma ,medicine.drug ,medicine.medical_specialty ,Oncology and Carcinogenesis ,Antineoplastic Agents ,Radiosurgery ,03 medical and health sciences ,Internal medicine ,medicine ,otorhinolaryngologic diseases ,Humans ,Meningeal Neoplasm ,Oncology & Carcinogenesis ,neoplasms ,business.industry ,Neurosciences ,Evaluation of treatments and therapeutic interventions ,medicine.disease ,RADIOTERAPIA ,Brain Disorders ,nervous system diseases ,Clinical trial ,Radiation therapy ,radiation ,Neurology (clinical) ,Cranial Irradiation ,business ,030217 neurology & neurosurgery - Abstract
Surgery has long been established as the first-line treatment for the majority of symptomatic and enlarging meningiomas, and evidence for its success is derived from retrospective case series. Despite surgical resection, a subset of meningiomas display aggressive behavior with early recurrences that are difficult to treat. The decision to radically resect meningiomas and involved structures is balanced against the risk for neurological injury in patients. Radiation therapy has largely been used as a complementary and safe therapeutic strategy in meningiomas with evidence primarily stemming from retrospective, single-institution reports. Two of the first cooperative group studies (RTOG 0539 and EORTC 22042) evaluating the outcomes of adjuvant radiation therapy in higher-risk meningiomas have shown promising preliminary results. Historically, systemic therapy has resulted in disappointing results in meningiomas. However, several clinical trials are under way evaluating the efficacy of chemotherapies, such as trabectedin, and novel molecular agents targeting Smoothened, AKT1, and focal adhesion kinase in patients with recurrent meningiomas.
- Published
- 2019
7. Imaging and diagnostic advances for intracranial meningiomas
- Author
-
Huang R. Y., Bi W. L., Griffith B., Kaufmann T. J., La Fougere C., Schmidt N. O., Tonn J. C., Vogelbaum M. A., Wen P. Y., Aldape K., Nassiri F., Zadeh G., Dunn I. F., Au K., Barnhartz-Sloan J., Brastianos P. K., Butowski N., Carlotti C., Cusimano M. D., Dimeco F., Drummond K., Galanis E., Giannini C., Goldbrunner R., Hashizume R., Hanemann C. O., Herold-Mende C., Horbinski C., James D., Jenkinson M. D., Jungk C., Kaufman T. J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J. C., Mamatjan Y., Mansouri A., Mawrin C., McDermott M., Munoz D., Noushmehr H., Ng H. -K., Perry A., Pirouzmand F., Poisson L. M., Pollo B., Raleigh D., Sahm F., Saladino A., Santarius T., Schichor C., Schultz D., Selman W., Sloan A., Spears J., Snyder J., Suppiah S., Tabatabai G., Tatagiba M., Tirapelli D., Tsang D., Deimling A. V., Walbert T., Westphal M., Workewych A. M., Huang R.Y., Bi W.L., Griffith B., Kaufmann T.J., La Fougere C., Schmidt N.O., Tonn J.C., Vogelbaum M.A., Wen P.Y., Aldape K., Nassiri F., Zadeh G., Dunn I.F., Au K., Barnhartz-Sloan J., Brastianos P.K., Butowski N., Carlotti C., Cusimano M.D., Dimeco F., Drummond K., Galanis E., Giannini C., Goldbrunner R., Hashizume R., Hanemann C.O., Herold-Mende C., Horbinski C., James D., Jenkinson M.D., Jungk C., Kaufman T.J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J.C., Mamatjan Y., Mansouri A., Mawrin C., McDermott M., Munoz D., Noushmehr H., Ng H.-K., Perry A., Pirouzmand F., Poisson L.M., Pollo B., Raleigh D., Sahm F., Saladino A., Santarius T., Schichor C., Schultz D., Selman W., Sloan A., Spears J., Snyder J., Suppiah S., Tabatabai G., Tatagiba M., Tirapelli D., Tsang D., Deimling A.V., Walbert T., Westphal M., and Workewych A.M.
- Subjects
Cancer Research ,medicine.medical_specialty ,Neuroimaging ,Supplement Articles ,Multimodal Imaging ,perfusion ,Meningioma ,03 medical and health sciences ,0302 clinical medicine ,Medical imaging ,medicine ,Meningeal Neoplasms ,Humans ,Meningeal Neoplasm ,Radiation treatment planning ,medicine.diagnostic_test ,business.industry ,imaging ,Magnetic resonance imaging ,medicine.disease ,radiology ,3. Good health ,Tumor detection ,RADIOLOGIA ,PET ,Oncology ,030220 oncology & carcinogenesis ,Radiological weapon ,Neurology (clinical) ,Radiology ,business ,030217 neurology & neurosurgery ,CT ,MRI - Abstract
The archetypal imaging characteristics of meningiomas are among the most stereotypic of all central nervous system (CNS) tumors. In the era of plain film and ventriculography, imaging was only performed if a mass was suspected, and their results were more suggestive than definitive. Following more than a century of technological development, we can now rely on imaging to non-invasively diagnose meningioma with great confidence and precisely delineate the locations of these tumors relative to their surrounding structures to inform treatment planning. Asymptomatic meningiomas may be identified and their growth monitored over time; moreover, imaging routinely serves as an essential tool to survey tumor burden at various stages during the course of treatment, thereby providing guidance on their effectiveness or the need for further intervention. Modern radiological techniques are expanding the power of imaging from tumor detection and monitoring to include extraction of biologic information from advanced analysis of radiological parameters. These contemporary approaches have led to promising attempts to predict tumor grade and, in turn, contribute prognostic data. In this supplement article, we review important current and future aspects of imaging in the diagnosis and management of meningioma, including conventional and advanced imaging techniques using CT, MRI, and nuclear medicine.
- Published
- 2019
8. C.05 Anticoagulant prophylaxis against venous thromboembolism following severe traumatic brain injury: a prospective observational study and systematic review
- Author
-
Hachem, LD, primary, Mansouri, A, additional, Scales, DC, additional, Geerts, W, additional, and Pirouzmand, F, additional
- Published
- 2018
- Full Text
- View/download PDF
9. P.098 Evaluation and surgical management of pelvic peripheral nerve sheath tumors: the University of Toronto experience and review of literature
- Author
-
Wang, S, primary, Merali, Z, additional, and Pirouzmand, F, additional
- Published
- 2017
- Full Text
- View/download PDF
10. Adaptation de l’angiographie, au vert d’indocyanine (VIC) à la Neurochirurgie
- Author
-
Schwartz, M., Fazl, M., Rowed, D., and Pirouzmand, F.
- Published
- 2006
- Full Text
- View/download PDF
11. Dural Sinus Thrombosis after Translabyrinthine Approach for Vestibular Schwannomas
- Author
-
Kumar, Ashish, primary, Pirouzmand, F., additional, and Chen, J., additional
- Published
- 2014
- Full Text
- View/download PDF
12. Intraoperative cytodiagnosis of progressive multifocal leucoencephalopathy
- Author
-
Keith, J., primary, Pirouzmand, F., additional, Diamandis, P., additional, and Ghorab, Z., additional
- Published
- 2013
- Full Text
- View/download PDF
13. Brain Metastasis from an Unknown Primary, or Primary Brain Tumour? A Diagnostic Dilemma
- Author
-
Campos, S., primary, Davey, P., additional, Hird, A., additional, Pressnail, B., additional, Bilbao, J., additional, Aviv, R. I., additional, Symons, S., additional, Pirouzmand, F., additional, Sinclair, E., additional, Culleton, S., additional, DeSa, E., additional, Goh, P., additional, and Chow, E., additional
- Published
- 2009
- Full Text
- View/download PDF
14. The Incidence Trends of Primary Brain Tumors in Saskatchewan from 1970 to 2001
- Author
-
Pirouzmand, F., primary and Sadanand, V., additional
- Published
- 2007
- Full Text
- View/download PDF
15. Anticoagulation Therapy Timing in patients with Atrial Fibrillation after Acute and Chronic Subdural Haematoma (ATTAACH): a pilot randomised controlled trial.
- Author
-
Mansouri A, Nassiri F, Scales D, and Pirouzmand F
- Subjects
- Humans, Pilot Projects, Stroke prevention & control, Stroke etiology, Hematoma, Subdural, Acute etiology, Male, Administration, Oral, Female, Randomized Controlled Trials as Topic, Time Factors, Atrial Fibrillation complications, Atrial Fibrillation drug therapy, Anticoagulants administration & dosage, Anticoagulants therapeutic use, Hematoma, Subdural, Chronic drug therapy
- Abstract
Introduction: Subdural haematomas (SDHs), acute or chronic, are common neurosurgical diagnoses. These problems can occur among patients requiring direct oral anticoagulation (DOAC) for atrial fibrillation. There are currently no guidelines regarding the optimal timing to resume anticoagulation for these patients after SDH. The objective of this study is to evaluate the feasibility of conducting a future large randomised controlled trial (RCT) evaluating the safety and efficacy of resuming DOACs early (ie, at 30 days) vs late (ie, at 3 months) for patients with atrial fibrillation following diagnosis of SDH., Methods and Analysis: This is a pilot, open-label, multicentre RCT that will enrol adults with newly diagnosed acute or chronic SDH with or without other intracranial bleeding who were receiving therapeutic anticoagulation with a DOAC as stroke prophylaxis for atrial fibrillation. Patients will be randomly allocated to resume a DOAC at standard dosing starting either days 30+7 or days 90±14. The primary outcomes for the pilot RCT are recruitment rate, protocol adherence and patient compliance with the randomly allocated interventions. Secondary outcomes are patient functional outcomes and safety and effectiveness outcomes, which will comprise key endpoints for the future planned RCT. This pilot RCT will provide important data to inform the feasibility of conducting a future, large RCT of early versus late resumption of DOACs for atrial fibrillation stroke prophylaxis in patients newly diagnosed with SDH. The future RCT will help inform management of a commonly encountered clinical dilemma with high associated morbidity and mortality., Ethics and Dissemination: This study has been approved by the research ethics board of record. It will be conducted in accordance with the Declaration of Helsinki, Good Clinical Practice guidelines and regulatory requirements. Informed consent will be obtained from eligible patients or substitute decision-makers. Data from this study will inform the design of future, larger RCTs., Trial Registration Number: NCT05472766., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
16. MEK Inhibition in a Pilocytic Astrocytoma With a Rare KRAS Q61R Mutation in a Young Adult Patient: A Case Report.
- Author
-
Roberto K, Keith J, Levine A, Pirouzmand F, Soliman H, and Lim-Fat MJ
- Subjects
- Female, Humans, Male, Young Adult, Protein Kinase Inhibitors therapeutic use, Astrocytoma genetics, Astrocytoma drug therapy, Brain Neoplasms genetics, Mutation, Proto-Oncogene Proteins p21(ras) genetics
- Abstract
This case illustrates the utility and impact of molecular testing and molecular tumor board discussion in the management of AYA patients with brain tumors.
- Published
- 2024
- Full Text
- View/download PDF
17. Dose-Escalated Radiation Therapy Is Associated With Improved Outcomes for High-Grade Meningioma.
- Author
-
Zeng KL, Soliman H, Myrehaug S, Tseng CL, Detsky J MD, Chen H MD, Lim-Fat MJ, Ruschin M, Atenafu EG, Keith J, Lipsman N, Heyn C, Maralani P, Das S, Pirouzmand F, and Sahgal A
- Subjects
- Humans, Progression-Free Survival, Proportional Hazards Models, Necrosis, Meningioma radiotherapy, Meningioma surgery, Meningeal Neoplasms radiotherapy, Meningeal Neoplasms surgery
- Abstract
Purpose: The optimal modern radiation therapy (RT) approach after surgery for atypical and malignant meningioma is unclear. We present results of dose escalation in a single-institution cohort spanning 2000 to 2021., Methods and Materials: Consecutive patients with histopathologic grade 2 or 3 meningioma treated with RT were reviewed. A dose-escalation cohort (≥66 Gy equivalent dose in 2-Gy fractions using an α/β = 10) was compared with a standard-dose cohort (<66 Gy). Outcomes were progression-free survival (PFS), cause-specific survival, overall survival (OS), local failure (LF), and radiation necrosis., Results: One hundred eighteen patients (111 grade 2, 94.1%) were identified; 54 (45.8%) received dose escalation and 64 (54.2%) standard dose. Median follow-up was 45.4 months (IQR, 24.0-80.0 months) and median OS was 9.7 years (Q1: 4.6 years, Q3: not reached). All dose-escalated patients had residual disease versus 65.6% in the standard-dose cohort (P < .001). PFS at 3, 4, and 5 years in the dose-escalated versus standard-dose cohort was 78.9%, 72.2%, and 64.6% versus 57.2%, 49.1%, and 40.8%, respectively, (P = .030). On multivariable analysis, dose escalation (hazard ratio [HR], 0.544; P = .042) was associated with improved PFS, whereas ≥2 surgeries (HR, 1.989; P = .035) and older age (HR, 1.035; P < .001) were associated with worse PFS. The cumulative risk of LF was reduced with dose escalation (P = .016). Multivariable analysis confirmed that dose escalation was protective for LF (HR, 0.483; P = .019), whereas ≥2 surgeries before RT predicted for LF (HR, 2.145; P = .008). A trend was observed for improved cause-specific survival and OS in the dose-escalation cohort (P < .1). Seven patients (5.9%) developed symptomatic radiation necrosis with no significant difference between the 2 cohorts., Conclusions: Dose-escalated RT with ≥66 Gy for high-grade meningioma is associated with improved local control and PFS with an acceptable risk of radiation necrosis., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
18. Virtual Reality Simulation for the Middle Cranial Fossa Approach: A Validation Study.
- Author
-
Lai C, Lui JT, de Lotbiniere-Bassett M, Chen JM, Lin VY, Agrawal SK, Blevins NH, Ladak HM, and Pirouzmand F
- Subjects
- Humans, Cranial Fossa, Middle surgery, Canada, Computer Simulation, Virtual Reality, Neurosurgery education
- Abstract
Background and Objectives: Virtual reality (VR) surgical rehearsal is an educational tool that exists in a safe environment. Validation is necessary to establish the educational value of this platform. The middle cranial fossa (MCF) is ideal for simulation because trainees have limited exposure to this approach and it has considerable complication risk. Our objectives were to assess the face, content, and construct validities of an MCF VR simulation, as well as the change in performance across serial simulations., Methods: Using high-resolution volumetric data sets of human cadavers, the authors generated a high-fidelity visual and haptic rendering of the MCF approach using CardinalSim software. Trainees from Neurosurgery and Otolaryngology-Head and Neck Surgery at two Canadian academic centers performed MCF dissections on this VR platform. Randomization was used to assess the effect of enhanced VR interaction. Likert scales were used to assess the face and content validities. Performance metrics and pre- and postsimulation test scores were evaluated. Construct validity was evaluated by examining the effect of the training level on simulation performance., Results: Twenty trainees were enrolled. Face and content validities were achieved in all domains. Construct validity, however, was not demonstrated. Postsimulation test scores were significantly higher than presimulation test scores ( P < .001 ). Trainees demonstrated statistically significant improvement in the time to complete dissections ( P < .001 ), internal auditory canal skeletonization ( P < .001 ), completeness of the anterior petrosectomy ( P < .001 ), and reduced number of injuries to critical structures ( P = .001 )., Conclusion: This MCF VR simulation created using CardinalSim demonstrated face and content validities. Construct validity was not established because no trainee included in the study had previous MCF approach experience, which further emphasizes the importance of simulation. When used as a formative educational adjunct in both Neurosurgery and Otolaryngology-Head and Neck Surgery, this simulation has the potential to enhance understanding of the complex anatomic relationships of critical neurovascular structures., (Copyright © Congress of Neurological Surgeons 2023. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
19. Delayed neurological improvement in a patient with Duret hemorrhage secondary to an acute subdural hematoma: illustrative case.
- Author
-
Jung Y, Ellenbogen Y, and Pirouzmand F
- Abstract
Background: Duret hemorrhage is a rare phenomenon wherein rapid transtentorial herniation results in brainstem injury and hemorrhage. It is usually regarded as a poor prognostic factor representing irreversible and often catastrophic brain injury. The authors report an unusual case of Duret hemorrhage with spontaneous delayed neurological recovery postoperatively after surgical treatment of an acute subdural hematoma (SDH)., Observations: The authors present the case of a 65-year-old male who initially presented to the hospital with a large acute left-sided SDH causing 1.3 cm of midline shift. He was taken urgently for a craniotomy, with no significant intraoperative swelling or visible contusions. Postoperative imaging revealed an unexpected pontine hyperdensity concerning for a Duret hemorrhage. He initially had no neurological improvement; however, at 3 weeks postoperatively, he gradually recovered and was able to follow commands and was extubated. At 10 weeks after surgery, his Glasgow Coma Scale score improved to 15, with mild residual left hemiparesis., Lessons: This case challenges a classic dogma that Duret hemorrhage carries a universally poor outcome. In select cases, patients can make meaningful recoveries in a delayed fashion. The lack of intraoperative contusions and swelling may have contributed to this patient's recovery.
- Published
- 2023
- Full Text
- View/download PDF
20. Application of mesenchymal stem cells in regenerative medicine: A new approach in modern medical science.
- Author
-
Ebrahimi F, Pirouzmand F, Cosme Pecho RD, Alwan M, Yassen Mohamed M, Ali MS, Hormozi A, Hasanzadeh S, Daei N, Hajimortezayi Z, and Zamani M
- Subjects
- Cell Differentiation, Umbilical Cord, Adipose Tissue, Regenerative Medicine methods, Mesenchymal Stem Cells
- Abstract
Mesenchymal Stem Cells (MSCs) are non-hematopoietic and multipotent stem cells, which have been considered in regenerative medicine. These cells are easily separated from different sources, such as bone marrow (BM), umbilical cord (UC), adipose tissue (AT), and etc. MSCs have the differentiation capability into chondrocytes, osteocytes, and adipocytes; This differentiation potential along with the paracrine properties have made them a key choice for tissue repair. MSCs also have various advantages over other stem cells, which is why they have been extensively studied in recent years. The effectiveness of MSCs-based therapies depend on several factors, including differentiation status at the time of use, concentration per injection, delivery method, the used vehicle, and the nature and extent of the damage. Although, MSCs have emerged promising sources for regenerative medicine, there are potential risks regarding their safety in their clinical use, including tumorigenesis, lack of availability, aging, and sensitivity to toxic environments. In this study, we aimed to discuss how MSCs may be useful in treating defects and diseases. To this aim, we will review recent advances of MSCs action mechanisms in regenerative medicine, as well as the most recent clinical trials. We will also have a brief overview of MSCs resources, differences between their sources, culture conditions, extraction methods, and clinical application of MSCs in various fields of regenerative medicine., (© 2023 American Institute of Chemical Engineers.)
- Published
- 2023
- Full Text
- View/download PDF
21. Ventral Spinal Epidural Venous Pouch in Spinal Epidural Venous Fistula.
- Author
-
Kapadia A, Maralani P, Pirouzmand F, and da Costa L
- Subjects
- Humans, Spine, Spinal Cord, Spinal Cord Diseases, Fistula, Central Nervous System Vascular Malformations, Embolization, Therapeutic
- Published
- 2023
- Full Text
- View/download PDF
22. Malignant Cerebellopontine Angle Peripheral Nerve Sheath Tumor with Divergent Mesenchymal (Cartilaginous) Differentiation Presenting with Catastrophic Hemorrhage: Case Report and Review.
- Author
-
Lai C, Bajin D, Chen JM, Dickson BC, Keith J, and Pirouzmand F
- Subjects
- Humans, Cerebellopontine Angle pathology, Hemorrhage etiology, Neurofibrosarcoma pathology, Neuroma, Acoustic complications, Neuroma, Acoustic surgery, Neuroma, Acoustic pathology, Neurofibromatoses pathology, Facial Paralysis
- Abstract
Malignant peripheral nerve sheath tumors of the cerebellopontine angle are rare, especially even outside of the context of neurofibromatosis or malignant transformation of previously radiated vestibular schwannomas. This case report describes a case of a presumed vestibular schwannoma without previous radiation or history of neurofibromatosis presenting with progressive hearing loss, facial weakness, growth, and ultimately catastrophic hemorrhage requiring urgent surgery. Histopathology revealed an exceptionally rare malignant peripheral nerve sheath tumor with divergent mesenchymal (chondrosarcomatous) differentiation with few rigorously interrogated cases in the literature. In retrospect, facial weakness, growth, and early intratumoral hemorrhage were harbingers of atypical malignant pathology. We advocate for a heightened index of suspicion, shorter interval follow-up, and consideration of early surgery in such cases in hopes of preventing potentially catastrophic outcomes.
- Published
- 2023
- Full Text
- View/download PDF
23. High-Fidelity Virtual Reality Simulation for the Middle Cranial Fossa Approach-Modules for Surgical Rehearsal and Education.
- Author
-
Lai C, Lui JT, Chen JM, Lin VY, Agrawal SK, Blevins NH, Ladak HM, and Pirouzmand F
- Subjects
- Humans, X-Ray Microtomography, Petrous Bone surgery, Computer Simulation, Cranial Fossa, Middle surgery, Cranial Fossa, Middle anatomy & histology, Virtual Reality
- Abstract
Background: Virtual reality simulation has gained prominence as a valuable surgical rehearsal and education tool in neurosurgery. Approaches to the internal auditory canal, cerebellopontine angle, and ventral brainstem region using the middle cranial fossa are not well explored by simulation., Objective: We hope to contribute to this paucity in simulation tools devoted to the lateral skull base, specifically the middle cranial fossa approach., Methods: Eight high-resolution microcomputed tomography scans of human cadavers were used as volumetric data sets to construct a high-fidelity visual and haptic rendering of the middle cranial fossa using CardinalSim software. Critical neurovascular structures related to this region of the skull base were segmented and incorporated into the modules., Results: The virtual models illustrate the 3-dimensional anatomic relationships of neurovascular structures in the middle cranial fossa and allow a realistic interactive drilling environment. This is facilitated by the ability to render bone opaque or transparent to reveal the proximity to critical anatomy allowing for practice of the virtual dissection in a graduated fashion., Conclusion: We have developed a virtual library of middle cranial fossa approach models, which integrate relevant neurovascular structures with aims to improve surgical training and education. A ready extension is the potential for patient-specific application and pathology., (Copyright © Congress of Neurological Surgeons 2022. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
24. Pre-Injury Antiplatelet Therapy and Risk of Adverse Outcomes after Traumatic Brain Injury: A Systematic Review and Meta-Analysis.
- Author
-
Mathieu F, Malhotra AK, Ku JC, Zeiler FA, Wilson JR, Pirouzmand F, and Scales DC
- Abstract
There is an increasing number of trauma patients presenting on pre-injury antiplatelet (AP) agents attributable to an aging population and expanding cardio- or cerebrovascular indications for antithrombotic therapy. The effects of different AP regimens on outcomes after traumatic brain injury (TBI) have yet to be elucidated, despite the implications on patient/family counseling and the potential need for better reversal strategies. The goal of this systematic review and meta-analysis was to assess the impact of different pre-injury AP regimens on outcomes after TBI. In accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, the OVID Medline, Embase, BIOSIS, Scopus, and Cochrane databases were searched from inception to February 2022 using a combination of terms pertaining to TBI and use of AP agents. Baseline demographics and study characteristics as well as outcome data pertaining to intracerebral hematoma (ICH) progression, need for neurosurgical intervention, hospital length of stay, mortality, and functional outcome were extracted. Pooled odds ratios (ORs) and mean differences comparing groups were calculated using random-effects models. Thirteen observational studies, totaling 1244 patients receiving single AP therapy with acetylsalicylic acid or clopidogrel, 413 patients on dual AP therapy, and 3027 non-AP users were included. No randomized controlled trials were identified. There were significant associations between dual AP use and ICH progression (OR, 2.81; 95% confidence interval [CI], 1.19-6.61; I
2 , 85%; p = 0.02) and need for neurosurgical intervention post-TBI (OR, 1.61; 95% CI, 1.15-2.28; I2 , 15%; p = 0.006) compared to non-users, but not between single AP therapy and non-users. There were no associations between AP use and hospital length of stay or mortality after trauma. Pre-injury dual AP use, but not single AP use, is associated with higher rates of ICH progression and neurosurgical intervention post-TBI. However, the overall quality of studies was low, and this association should be further investigated in larger studies., Competing Interests: F.A.Z. receives research support from the Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment; the Health Sciences Centre Foundation Winnipeg; the Canada Foundation for Innovation (CFI; Project No.: 38583); Research Manitoba (Grant No.: 3906); the University of Manitoba VPRI Research Investment Fund (RIF); and the University of Manitoba Rudy Falk Clinician-Scientist Professorship. D.C.S. holds operating grants from the Canadian Institute for Health Research., (© François Mathieu et al., 2022; Published by Mary Ann Liebert, Inc.)- Published
- 2022
- Full Text
- View/download PDF
25. A phase II pilot randomized controlled trial to assess the feasibility of the "supra-marginal" surgical resection of malignant glioma (G-SUMIT: Glioma supra marginal incision trial) study protocol.
- Author
-
Mansouri A, Lai C, Scales D, and Pirouzmand F
- Abstract
Background: High-grade gliomas are the most common primary malignant brain tumor in adults having a median survival of only 13-16 months. This is despite the current standard of maximal safe surgical resection followed by fractionated radiotherapy and chemotherapy. Extending the tumor resection limit beyond the gadolinium (GAD)-enhancing margin (i.e., supra-marginal resection) could in principle provide an added survival benefit as it has been shown that > 80% of post-operative tumor recurrence is within a 2-cm region surrounding the original GAD-enhancing margin. However, this must be weighed against the risk of potential damage to functional brain tissue., Methods: In this phase II pilot randomized control trial (RCT), we aim to assess the feasibility of "supra-marginal" resection extending 1 cm beyond the enhancing tumor in adults with radiographic evidence of GAD-enhancing intra-axial tumor consistent with high-grade glioma in a safe anatomical location and a Karnofsky Performance Score > 60. With six academic institutions with established neurosurgical oncology practices in participation, we aim to enroll 72 patients over 2 years. Primary outcomes include evaluating the feasibility of performing a large-scale trial with regard to recruitment, allocation, and outcome documentation as well as safety data. Secondary outcomes include determining if there is an increased survival benefit with supra-marginal resection and impact on quality of life (Modified Rankin Scale (mRS), EuroQol-5D (ED-5D), 30-day all-cause mortality)., Discussion: Recent studies have revealed survival advantages comparing supra-marginal resection to standard attempt at gross total resection (GTR) with no additional perioperative surgical risk; however, the current quality of evidence is low and under-powered. Therefore, there are no current practice guidelines, and the philosophy of surgical resection is guided by individual surgeon preferences on an individual patient basis. This creates additional uncertainty and is potentially detrimental to our patients. This clinical equipoise supports the need for an adequately powered RCT to determine whether a supra-marginal resection can have a positive impact on survival for patients with HGGs. Our pilot RCT will test the feasibility of comparing the standard gross total resection of GAD-enhancing tumors and supra-marginal resection to prepare for a larger definitive multicenter RCT., Trial Registration: ClinicalTrials.gov , NCT04737577. Registered on February 4, 2021., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
26. Development and validation of a patient-centered, meningioma-specific quality-of-life questionnaire.
- Author
-
Baba A, Saha A, McCradden MD, Boparai K, Zhang S, Pirouzmand F, Edelstein K, Zadeh G, and Cusimano MD
- Abstract
Objective: Meningiomas can have significant impact on health-related quality of life (HRQOL). Patient-centered, disease-specific instruments for assessing HRQOL in these patients are lacking. To this end, the authors sought to develop and validate a meningioma-specific HRQOL questionnaire through a standardized, patient-centered questionnaire development methodology., Methods: The development of the questionnaire involved three main phases: item generation, item reduction, and validation. Item generation consisted of semistructured interviews with patients (n = 30), informal caregivers (n = 12), and healthcare providers (n = 8) to create a preliminary list of items. Item reduction with 60 patients was guided by the clinical impact method, multiple correspondence analysis, and hierarchical cluster analysis. The validation phase involved 162 patients and collected evidence on extreme-groups validity; concurrent validity with the SF-36, FACT-Br, and EQ-5D; and test-retest reliability. The questionnaire takes on average 11 minutes to complete., Results: The meningioma-specific quality-of-life questionnaire (MQOL) consists of 70 items representing 9 domains. Cronbach's alpha for each domain ranged from 0.61 to 0.91. Concurrent validity testing demonstrated construct validity, while extreme-groups testing (p = 1.45E-11) confirmed the MQOL's ability to distinguish between different groups of patients., Conclusions: The MQOL is a validated, reliable, and feasible questionnaire designed specifically for evaluating QOL in meningioma patients. This disease-specific questionnaire will be fundamentally helpful in better understanding and capturing HRQOL in the meningioma patient population and can be used in both clinical and research settings.
- Published
- 2021
- Full Text
- View/download PDF
27. Management of Diffuse Low-Grade Glioma: The Renaissance of Robust Evidence.
- Author
-
Brar K, Hachem LD, Badhiwala JH, Mau C, Zacharia BE, de Moraes FY, Pirouzmand F, and Mansouri A
- Abstract
The surgical management of diffuse low-grade gliomas (DLGGs) has undergone a paradigm shift toward striving for maximal safe resection when feasible. While extensive observational data supports this transition, unbiased evidence in the form of high quality randomized-controlled trials (RCTs) is lacking. Furthermore, despite a high volume of molecular, genetic, and imaging data, the field of neuro-oncology lacks personalized care algorithms for individuals with DLGGs based on a robust foundation of evidence. In this manuscript, we (1) discuss the logistical and philosophical challenges hindering the development of surgical RCTs for DLGGs, (2) highlight the potential impact of well-designed international prospective observational registries, (3) discuss ways in which cutting-edge computational techniques can be harnessed to generate maximal insight from high volumes of multi-faceted data, and (4) outline a comprehensive plan of action that will enable a multi-disciplinary approach to future DLGG management, integrating advances in clinical medicine, basic molecular research and large-scale data mining., (Copyright © 2020 Brar, Hachem, Badhiwala, Mau, Zacharia, Moraes, Pirouzmand and Mansouri.)
- Published
- 2020
- Full Text
- View/download PDF
28. Reinitiation of Anticoagulation After Surgical Evacuation of Subdural Hematomas.
- Author
-
Nassiri F, Hachem LD, Wang JZ, Badhiwala JH, Zadeh G, Gladstone D, Scales DC, and Pirouzmand F
- Subjects
- Administration, Oral, Adult, Hemorrhage chemically induced, Humans, Postoperative Care, Risk Factors, Stroke chemically induced, Anticoagulants administration & dosage, Hematoma, Subdural, Chronic surgery
- Abstract
Background: Chronic subdural hematoma (cSDH) is an increasingly common condition due to the growing use of anticoagulation. Currently, there remains a lack of evidence to guide the optimal timing of anticoagulant reinitiation for stroke prevention in atrial fibrillation after cSDH evacuation. We aimed to better understand the perceived risks of hemorrhagic and embolic complications along with current practice patterns on restarting anticoagulation after surgical evacuation of cSDH., Methods: We conducted a survey of Canadian neurosurgeons and stroke neurologists using a novel self-administered questionnaire using clinical cases that included questions on clinical experience, practice setting, practice patterns, and perceptions on stroke/bleeding risk with anticoagulation reinitiation after cSDH evacuation. The instrument was evaluated for clinical sensibility by 5 neurosurgeons, neurologists, and intensivists., Results: The response rate after 4 mailings was 40% for neurosurgeons (55/136) and 21% for stroke neurologists (26/122). Almost all participants would restart anticoagulation for stroke prevention in atrial fibrillation after cSDH evacuation (91.8% in low-risk patients, 98.6% in high-risk patients). Time to reinitiation of anticoagulation varied considerably, particularly for high-risk patients where 36% of participants would restart anticoagulation within 1 week of surgery, 44% between 1 and 4 weeks after surgery, and 19% after 4 weeks postoperatively. The perceived risk of stroke and SDH reaccumulation varied considerably among participants and was dependent on timing of anticoagulation reinitiation., Conclusions: There is considerable variation in current practice patterns and perceived risks of embolic and hemorrhagic complications with anticoagulation reinitiation after cSDH evacuation. These results demonstrate clinical equipoise that warrant further targeted investigation in large-scale randomized controlled trials., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
29. Novel Statistical Analyses to Assess Hearing Outcomes After ABI Implantation in NF2 Patients: Systematic Review and Individualized Patient Data Analysis.
- Author
-
Taslimi S, Zuccato JA, Mansouri A, Hachem LD, Badhiwala J, Kuchta J, Chen J, and Pirouzmand F
- Subjects
- Auditory Perception, Hearing Loss, Bilateral etiology, Hearing Loss, Sensorineural etiology, Humans, Statistics as Topic, Treatment Outcome, Auditory Brain Stem Implantation, Hearing Loss, Bilateral rehabilitation, Hearing Loss, Sensorineural rehabilitation, Lipreading, Neurofibromatosis 2 complications, Neuroma, Acoustic complications, Speech Perception
- Abstract
Background: Patients with neurofibromatosis type 2 develop bilateral vestibular schwannomas with progressive hearing loss. Auditory brainstem implants (ABIs) stimulate hearing in the cochlear nuclei and show promise in improving hearing. Here, we assess the impact of ABI on hearing over time by systematically reviewing the literature and re-analyzing available individual patient data., Methods: A multidatabase search identified 3 studies with individual patient data of longitudinal hearing outcomes after ABI insertion in adults. Data were collected on hearing outcomes of different sound complexities from sound to speech using an ABI ± lip reading ability plus demographic data. Because of heterogeneity each study was analyzed separately using random effects multilevel mixed linear modeling., Results: Across all 3 studies (n = 111 total) there were significant improvements in hearing over time from ABI placement (P < 0.000 in all). Improvements in comprehension of sounds, words, sentences, and speech occurred over time with ABI use + lip reading but lip reading ability did not improve over time. All categories of hearing complexity had over 50% comprehension after over 1 year of ABI use and some subsets had over 75% or near 100% comprehension. Vowel comprehension was greater than consonant, and word comprehension was greater than sentence comprehension (P < 0.0001 in both). Age and sex did not predict outcomes., Conclusions: ABIs improve hearing beyond lip reading alone, which represents baseline patient function prior to treatment, and the benefits continue to improve with time. These findings may be used to guide patient counseling regarding ABI insertion, rehabilitation course after insertion, and future studies., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
30. Anticoagulant prophylaxis against venous thromboembolism following severe traumatic brain injury: A prospective observational study and systematic review of the literature.
- Author
-
Hachem LD, Mansouri A, Scales DC, Geerts W, and Pirouzmand F
- Subjects
- Adult, Aged, Aged, 80 and over, Brain Injuries, Traumatic diagnostic imaging, Brain Injuries, Traumatic mortality, Female, Humans, Male, Middle Aged, Prospective Studies, Treatment Outcome, Venous Thromboembolism diagnostic imaging, Venous Thromboembolism mortality, Young Adult, Anticoagulants administration & dosage, Brain Injuries, Traumatic drug therapy, Post-Exposure Prophylaxis methods, Severity of Illness Index, Venous Thromboembolism prevention & control
- Abstract
Objectives: Venous thromboembolism (VTE) is a serious complication following severe traumatic brain injury (TBI), however, anticoagulant prophylaxis remains controversial due to concerns of intracranial hemorrhage (ICH) progression. We examined anticoagulant prophylaxis practice patterns at a major trauma centre and determined risk estimates for VTE and ICH progression classified by timing of anticoagulant initiation., Patients and Methods: A 1-year prospective analysis of consecutive patients with severe TBI admitted to a Level-I trauma centre was conducted. In addition, we systematically reviewed the literature to identify studies on VTE and anticoagulant prophylaxis after severe TBI., Results: 64 severe TBI patients were included. 83% of patients received anticoagulant prophylaxis, initiated ≥3d post-TBI in 67%. The in-hospital VTE incidence was 16% and there was no significant difference between patients who received early (<3d) versus late (≥3d) prophylaxis (10% vs. 16%). Rates of ICH progression (0% vs. 7%) were similar between groups. Our systematic review identified 5 studies with VTE rates ranging from 5 to 10% with prophylaxis, to 11-30% without prophylaxis. The effect of timing of anticoagulant prophylaxis initiation on ICH progression was not reported in any study., Conclusion: VTE is a common complication after severe TBI. Anticoagulant prophylaxis is often started late (≥3d) post-injury. Randomized trials are justifiable and necessary to provide practice guidance with regards to optimal timing of anticoagulant prophylaxis., (Copyright © 2018 Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
31. Somatosensory evoked potentials after decompressive craniectomy for traumatic brain injury.
- Author
-
Bethune A, Scantlebury N, Potapova E, Dinn N, Yang V, Mainprize T, Fazl M, Pirouzmand F, da Costa L, Chapman M, and Phan N
- Subjects
- Adult, Aged, Brain Neoplasms physiopathology, Brain Neoplasms surgery, Cohort Studies, Female, Humans, Intraoperative Neurophysiological Monitoring statistics & numerical data, Male, Prognosis, Brain Injuries, Traumatic physiopathology, Brain Injuries, Traumatic surgery, Decompressive Craniectomy, Evoked Potentials, Somatosensory physiology, Intraoperative Neurophysiological Monitoring methods
- Abstract
Somatosensory evoked potentials (SSEPs) are used for neuroprognosis after severe traumatic brain injury (TBI). However decompressive craniectomy (DC), involving removal of a portion of the skull to alleviate elevated intracranial pressure, is associated with an increase in SSEP amplitude. Accordingly, SSEPs are not available for neuroprognosis over the hemisphere with DC. We aim to determine the degree to which SSEP amplitudes are increased in the absence of cranial bone. This will serve as a precursor for translation to clinically prognostic ranges. Intra-operative SSEPs were performed before and after bone flap replacement in 22 patients with severe TBI. SSEP measurements were also performed in a comparison non-traumatic group undergoing craniotomy for tumor resection. N20/P25 amplitudes and central conduction time were measured with the bone flap in (BI) and out (BO). Linear regressions, adjusting for skull thickness and study arm, were performed to evaluate the contribution of bone presence to SSEP amplitudes. Latencies were not different between BO or BI trials in either group. Mean N20/P25 amplitudes recorded with BO were statistically different (p = 0.0001) from BI in both cohorts, showing an approximate doubling in BO amplitudes. For contralateral-ipsilateral montages r
2 was 0.28 and for frontal pole montages r2 was 0.62. Cortical SSEP amplitudes are influenced by the presence of cortical bone as is particularly evident in frontal pole montages. Larger, longitudinal trials to assess feasibility of neuroprognosis over the hemisphere with DC in severe TBI patients are warranted.- Published
- 2018
- Full Text
- View/download PDF
32. Feasibility of real-time intraoperative fluorescence imaging of dural sinus thrombosis.
- Author
-
Hachem LD, Mansouri A, Chen J, and Pirouzmand F
- Subjects
- Female, Fluorescence, Humans, Indocyanine Green, Middle Aged, Neuroma, Acoustic surgery, Phlebography methods, Tomography, X-Ray Computed methods, Cerebral Angiography methods, Neuroimaging methods, Neurosurgical Procedures adverse effects, Sinus Thrombosis, Intracranial diagnostic imaging, Sinus Thrombosis, Intracranial etiology
- Abstract
Dural sinus thrombosis is a well-recognized and potentially serious complication following lateral skull base surgery. Methods of diagnosis are limited to post-operative computerized tomography scans or magnetic resonance venography. There are currently no reports of an intraoperative technique used to detect dural sinus thrombosis. Here, we describe the case of a 62-year-old woman who underwent translabyrinthine resection of a right vestibular schwannoma with no evidence of sinus thrombosis on pre-operative scans. Following tumor resection, patency of the sigmoid sinus was assessed intraoperatively using indocyanine green (ICG) videography which revealed a lack of flow in the right sigmoid sinus. Postoperative CT scan confirmed thrombosis of the right sigmoid sinus. We present the first report of real-time intraoperative diagnosis of sigmoid sinus thrombosis during removal of a vestibular schwannoma. ICG videography may be used for intraoperative visualization of dural sinus integrity and patency during prolonged or technically challenging microsurgical procedures. This technique may enable periodic monitoring and early identification of filling defects which can guide further intraoperative strategies and postoperative monitoring., (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
33. The clinical significance of isolated traumatic subarachnoid hemorrhage in mild traumatic brain injury: A meta-analysis.
- Author
-
Nassiri F, Badhiwala JH, Witiw CD, Mansouri A, Davidson B, Almenawer SA, Lipsman N, Da Costa L, Pirouzmand F, and Nathens AB
- Subjects
- Disease Progression, Glasgow Coma Scale, Humans, Neurosurgical Procedures, Brain Concussion surgery, Subarachnoid Hemorrhage, Traumatic surgery
- Abstract
Background: The rates of clinical and radiographic progression and the need for neurosurgical intervention in patients with isolated traumatic subarachnoid hemorrhage (itSAH) after mild traumatic brain injury (Glasgow Coma Scale score, 13-15) has not been well established.The aim of this work was to review the evidence regarding patient outcomes after mild traumatic brain injury with itSAH., Methods: Two authors independently extracted the data according to a predefined protocol. The proportions of patients who had the outcomes of interest were pooled using random-effects model. The quality of included studies was assessed using the methodological index for nonrandomized studies scale., Results: Thirteen studies reporting on 15,327 patients met inclusion criteria, and outcomes were pooled where available. No patient required neurosurgical intervention on presentation to hospital, and the incidence of need for eventual neurosurgical intervention was 0.0017% (95% confidence interval [CI], 0-0.39%). Moreover, the pooled analyses for all patients with available data showed an incidence of 5.76% (95% CI, 1.18-12.94%) for radiographic progression, 0.75% (95% CI, 0-2.39%) for neurologic deterioration, and 0.60% (95% CI, 0.09-1.41%) for mortality. Only one patient had died due to neurological injury., Conclusions: These patients experience very low rates of radiographic progression and neurologic deterioration and rarely require neurosurgical intervention or die due to neurological injury., Level of Evidence: Meta-analysis, level III.
- Published
- 2017
- Full Text
- View/download PDF
34. Citation classics in neuro-oncology: assessment of historical trends and scientific progress.
- Author
-
Hachem LD, Mansouri A, Juraschka K, Taslimi S, Pirouzmand F, and Zadeh G
- Subjects
- Animals, Humans, Medical Oncology statistics & numerical data, Neurology statistics & numerical data, Journal Impact Factor, Medical Oncology trends, Neurology trends
- Abstract
Background: Citation classics represent the highest cited works in a field and are often regarded as the most influential literature. Analyzing thematic trends in citation classics across eras enables recognition of important historical advances within a field. We present the first analysis of the citation classics in neuro-oncology., Methods: The Web of Science database was searched using terms relevant to "neuro-oncology." Articles with >400 citations were identified and the top 100 cited articles were evaluated., Results: The top 100 neuro-oncology citation classics consisted of 43 clinical studies (17 retrospective, 10 prospective, 16 randomized trials), 43 laboratory investigations, 8 reviews/meta-analyses, and 6 guidelines/consensus statements. Articles were classified into 4 themes: 13 pertained to tumor classification, 37 to tumor pathogenesis/clinical presentation, 6 to imaging, 44 to therapy (15 chemotherapy, 10 radiotherapy, 5 surgery, 14 new agents). Gliomas were the most common tumor type examined, with 70 articles. There was a significant increase in the number of citation classics in the late 1990s, which was paralleled by an increase in studies examining tumor pathogenesis, chemotherapy, and new agents along with laboratory and randomized studies., Conclusions: The majority of citation classics in neuro-oncology are related to gliomas and pertain to tumor pathogenesis and treatment. The rise in citation classics in recent years investigating tumor biology, new treatment agents, and chemotherapeutics may reflect increasing scientific interest in nonsurgical treatments for CNS tumors and the need for fundamental investigations into disease processes., (© The Author(s) 2017. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com)
- Published
- 2017
- Full Text
- View/download PDF
35. Lumbar discal cyst as a cause of radiculopathy: case report.
- Author
-
Cho N, Keith J, and Pirouzmand F
- Subjects
- Adult, Cysts diagnostic imaging, Cysts surgery, Female, Humans, Intervertebral Disc Displacement etiology, Intervertebral Disc Displacement surgery, Magnetic Resonance Imaging, Neurosurgical Procedures, Radiculopathy diagnostic imaging, Cysts complications, Intervertebral Disc, Lumbosacral Region, Radiculopathy etiology
- Abstract
Lumbar discal cysts are rare entities causing radicular pain with unknown etiologies. We report a case of a 42-year-old man who developed radiculopathy secondary to a lumbar discal cyst. Our case sheds some light on anatomy, possible etiological association and clinical course which can help management.
- Published
- 2016
- Full Text
- View/download PDF
36. Timing of Pharmacologic Venous Thromboembolism Prophylaxis in Severe Traumatic Brain Injury: A Propensity-Matched Cohort Study.
- Author
-
Byrne JP, Mason SA, Gomez D, Hoeft C, Subacius H, Xiong W, Neal M, Pirouzmand F, and Nathens AB
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Anticoagulants therapeutic use, Drug Administration Schedule, Female, Heparin therapeutic use, Heparin, Low-Molecular-Weight adverse effects, Heparin, Low-Molecular-Weight therapeutic use, Humans, Intracranial Hemorrhages chemically induced, Intracranial Hemorrhages prevention & control, Logistic Models, Male, Middle Aged, Propensity Score, Pulmonary Embolism etiology, Retrospective Studies, Treatment Outcome, Venous Thrombosis etiology, Young Adult, Anticoagulants administration & dosage, Brain Injuries, Traumatic complications, Heparin administration & dosage, Pulmonary Embolism prevention & control, Venous Thrombosis prevention & control
- Abstract
Background: Patients with severe traumatic brain injury (sTBI) are at high risk for developing venous thromboembolism (VTE). Nonetheless, pharmacologic VTE prophylaxis is often delayed out of concern for precipitating extension of intracranial hemorrhage (ICH). The purpose of this study was to compare the effectiveness of early vs late VTE prophylaxis in patients with sTBI, and to characterize the risk of subsequent ICH-related complication., Study Design: Adults with isolated sTBI (head Abbreviated Injury Scale score ≥3 and total Glasgow Coma Scale score ≤8) who received VTE prophylaxis with low-molecular-weight or unfractionated heparin were derived from the American College of Surgeons Trauma Quality Improvement Program (2012 to 2014). Patients were divided into EP (<72 hours) or LP (≥72 hours) groups. Propensity score matching was used to minimize selection bias. The primary end point was VTE (pulmonary embolism or deep vein thrombosis). Secondary outcomes were defined as late neurosurgical intervention (≥72 hours) or death., Results: We identified 3,634 patients with sTBI. Early prophylaxis was given in 43% of patients. Higher head injury severity, presence of ICH, and early neurosurgery were associated with late prophylaxis. Propensity score matching yielded a well-balanced cohort of 2,468 patients. Early prophylaxis was associated with lower rates of both pulmonary embolism (odds ratio = 0.48; 95% CI, 0.25-0.91) and deep vein thrombosis (odds ratio = 0.51; 95% CI, 0.36-0.72), but no increase in risk of late neurosurgical intervention or death., Conclusions: In this observational study of patients with sTBI, early initiation of VTE prophylaxis was associated with decreased risk of pulmonary embolism and deep vein thrombosis, but no increase in risk of late neurosurgical intervention or death. Early prophylaxis may be safe and should be the goal for each patient in the context of appropriate risk stratification., (Copyright © 2016 American College of Surgeons. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
37. Obtuse-angled Laminotomy as a Modification of Multilevel Laminectomy for Spinal Cord Decompression.
- Author
-
Jhas S and Pirouzmand F
- Subjects
- Humans, Decompression, Surgical methods, Laminectomy methods, Spinal Cord Compression surgery
- Abstract
The purpose of this note is to describe an obtuse-angled laminotomy of C7 during cervical decompression that aims to preserve cervicothoracic junction stability and potentially reduce pain. Cervical spondylotic myelopathy can result from degenerative cervical spinal disease including, herniated disk material, osteophytes, redundant ligamentum flavum, or ossification of the posterior longitudinal ligament. Surgical intervention for multilevel myelopathy aims to decompress the spinal cord and maintain stability of the cervical spine. Multilevel laminectomy is traditionally used when degenerative changes affect 3 or more levels and when there is primarily dorsal compressive disease. Traditional laminectomy can result in instability and kyphosis. The C7 lamina can be particularly vulnerable given the location at cervicothoracic junction. We describe an obtuse-angled laminotomy for the most caudal lamina in a planned decompression. This lamina is left attached to ligamentum nuchea, adjacent fascia, and paravertebral muscles. Only the base of spinous process and ventral portion of lamina's cortical and cancellous bone are removed in an obtuse angle through the opening. This variation is aimed to preserve as much of the cervical stability while still achieving the goal of decompression.
- Published
- 2016
- Full Text
- View/download PDF
38. A simple method for controlled reduction duraplasty during cranioplasty.
- Author
-
Yang VX and Pirouzmand F
- Subjects
- Female, Humans, Male, Craniotomy methods, Encephalocele surgery, Plastic Surgery Procedures methods, Skull surgery, Surgical Flaps
- Abstract
Background: Bone flap re-approximation during cranioplasty can be complicated by underlying pseudomeningocele or meningoencephalocele. A technique for controlled reduction duraplasty to aid bone flap positioning is suggested., Methods: A simple method using bipolar electrocautery in a predetermined radial pattern from the center of defect is described. Localized tissue contraction allows controlled reduction in the surface area and degree of protrusion. This in turn facilitates bone flap positioning., Results: The main advantage of this technique is slow and evenly distributed pressure conferred by controlled tissue contraction using multiple radial coagulation lines. No technical difficulties or complications have occurred with this method during cranioplasty for 11 patients., Conclusion: This simple technique for controlled reduction duraplasty can provide an easy and efficient method for bone flap re-approximation, and add to the existing techniques for a commonly performed procedure.
- Published
- 2016
- Full Text
- View/download PDF
39. Facial nerve prognostication in vestibular schwannoma surgery: the concept of percent maximum and its predictability.
- Author
-
Arnoldner C, Mick P, Pirouzmand F, Houlden D, Lin VY, Nedzelski JM, and Chen JM
- Subjects
- Adult, Aged, Electromyography, Female, Humans, Male, Middle Aged, Recovery of Function physiology, Sensitivity and Specificity, Young Adult, Facial Nerve physiopathology, Intraoperative Neurophysiological Monitoring, Neuroma, Acoustic physiopathology, Neuroma, Acoustic surgery
- Abstract
Objectives/hypothesis: To evaluate percent maximum as an intraoperative facial nerve measurement for the long-term prognostication of vestibular schwannoma surgery., Study Design: Prospective cohort study., Methods: Evoked amplitude responses to varying levels of stimulus intensity at the nerve root were compared to their supramaximal responses (Mmax) as a percentage, that is, percent maximum. Response charts were constructed for each of the levels of stimulus intensity between 0.05 to 0.3 mA, vis-à-vis facial nerve outcome at 1 year, to establish sensitivities, specificities, and positive predictive values. Logistic regression analyses were used to determine the impact of sex, age, tumor size, and historically defined response parameter on outcomes., Results: Seventy-eight patients who underwent vestibular schwannoma surgeries between 2005 and 2010 were studied. The positive predictive value (PPV) of a good facial nerve outcome, defined as House-Brackmann (HB) I-II, increases with percent maximum responses. A 90% PPV could be established when the response amplitude was 50% or greater compared to Mmax. Long-term prognostication appeared best at a higher stimulus level of 0.3 mA. Age and sex did not have an impact on outcome, but tumor size did; with each centimeter increase in tumor size, patients were 105% more likely to have a poor outcome (HB III-VI). If the response parameter "≥240 μV at 0.05 mA" was not present, there was a trend toward poor outcome., Conclusions: Percent maximum is a valid intraoperative monitoring measure to prognosticate long-term facial nerve outcome. It should be considered a complementary method of monitoring when evoked responses do not conform to conventional predictors., Level of Evidence: 4., (Copyright © 2013 The American Laryngological, Rhinological and Otological Society, Inc.)
- Published
- 2013
- Full Text
- View/download PDF
40. Optimal intraoperative somatosensory evoked potential stimulus intensity can be determined by nerve action potential amplitude.
- Author
-
Houlden DA, Ubriaco G, Stewart CP, Robertson SL, Cohen M, Potapova E, and Pirouzmand F
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Tibial Nerve physiology, Ulnar Nerve physiology, Action Potentials physiology, Evoked Potentials, Somatosensory physiology, Monitoring, Intraoperative methods, Neurosurgical Procedures methods
- Abstract
Purpose: Muscle twitch threshold has been used to determine optimal stimulus intensity for somatosensory evoked potentials but neuromuscular blockade precludes the use of muscle twitch during surgery. Accordingly, nerve action potential (NAP) amplitude was investigated as a surrogate to muscle twitch., Methods: The ulnar and tibial nerves were stimulated at the wrist and ankle, respectively, in 27 patients undergoing spine and brain surgery. After neuromuscular blockade was gone, the stimulus intensity for just maximal NAP amplitude recorded from Erb's point and the popliteal fossa was compared with the stimulus intensity for hypothenar and plantar foot muscle twitch threshold (times two), respectively (Wilcoxon matched pairs test)., Results: There was no significant difference between stimulus intensity for just maximal Erb's point and popliteal fossa NAP amplitude when compared with stimulus intensity for hypothenar and plantar foot twitch threshold (times two), respectively. Eight patients required more than twitch intensity (times two) to obtain maximum NAP., Conclusions: The NAP amplitude may be used to determine optimal somatosensory evoked potential stimulus intensity when muscle twitch is not visible. This method should improve the success of intraoperative somatosensory evoked potential monitoring and decrease erroneous interpretation.
- Published
- 2012
- Full Text
- View/download PDF
41. Quantitative volumetric analysis post transsphenoidal pituitary adenoma surgery.
- Author
-
Mansouri A, Symons S, Schwartz M, Chen J, and Pirouzmand F
- Subjects
- Female, Follow-Up Studies, Humans, Hypophysectomy, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Male, Postoperative Period, Retrospective Studies, Sella Turcica surgery, Tomography Scanners, X-Ray Computed, Treatment Outcome, Adenoma pathology, Adenoma surgery, Pituitary Neoplasms pathology, Pituitary Neoplasms surgery
- Abstract
Background: Computed tomogram (CT) imaging is often used for immediate postoperative assessment of transsphenoidal pituitary adenoma resection while magnetic resonance imaging (MRI) is used for follow-up. The residual mass is known to decrease in size over time but the difference between the two imaging modalities has not been quantified. Our objective was to quantify the size difference of the residual mass on immediate postoperative CT compared with delayed MRI., Methods: Retrospective analysis of 69 patients who had undergone pituitary adenoma resection at our institution between 2004-2010. Sellar and suprasellar diameter, along with the overall volume of the residual mass were measured on both the immediate postoperative CT and delayed MRI., Results: Average preoperative sellar and suprasellar diameter was 22.2 ± 4.6mm and 20.9 ± 5.9mm, respectively. Average sellar residual diameter on immediate postoperative CT (16.5 ± 5.4 mm, 25% reduction) was significantly larger than delayed MRI (10.6 ± 6.2mm, 52% reduction). The average suprasellar component on CT (15.5±6.5mm, 26% reduction) was also significantly larger than that on MRI (3.3 ± 5.4 mm, 84% reduction). The postoperative CT showed a 46% reduction in volume while a 71% reduction was noted on the delayed MRI., Conclusion: A significant reduction in residual mass is noted on delayed MR imaging compared with immediate postoperative CT. Therefore, from a resource management and prognostication point of view, CT should be used for immediate postoperative assessment while delayed MRI should be used to assess operative success and for communication with patients.
- Published
- 2012
- Full Text
- View/download PDF
42. Synovial sarcoma of the brachial plexus: case report.
- Author
-
Pirouzmand F, Kommaraju K, Craddock KJ, and Howarth D
- Subjects
- Female, Humans, Middle Aged, Treatment Outcome, Brachial Plexus surgery, Sarcoma, Synovial diagnosis, Sarcoma, Synovial surgery
- Abstract
Background and Importance: Synovial sarcoma (SS) is a malignant soft-tissue tumor that rarely involves brachial plexus. The authors report a case of brachial plexus SS and review the relevant literature., Clinical Presentation: A 53-year-old woman presented with gradually enlarging right subclavicular mass over 5 years associated with sharp aching pain radiating down toward the radial 3 fingers. On examination, she had a corresponding firm mass in the supraclavicular region with a positive Tinel sign. There was no objective neurological deficit. She underwent partial excision of this mass without any further adjuvant radiation or chemotherapy. Pathology was consistent with SS., Conclusion: Lack of any recurrence in this case 6 years after incomplete excision with no adjuvant therapy suggests slow clinical course in some of these sarcomas.
- Published
- 2012
- Full Text
- View/download PDF
43. Epidemiological trends of traumatic optic nerve injuries in the largest Canadian adult trauma center.
- Author
-
Pirouzmand F
- Subjects
- Adult, Chi-Square Distribution, Female, Humans, Injury Severity Score, Length of Stay statistics & numerical data, Male, Ontario epidemiology, Regression Analysis, Retrospective Studies, Risk Factors, Statistics, Nonparametric, Trauma Centers, Optic Nerve Injuries epidemiology
- Abstract
Background: There has been a paucity of information on the epidemiology of traumatic optic neuropathy (TON). This study documents epidemiology of TON over 2 decades in the largest level I adult trauma center in Canada., Methods: Data on all the trauma patients admitted to Sunnybrook Health Sciences Centre from 1986 to 2007 were collected in a prospective database. The aggregate data on optic nerve injuries including demographic data, etiology, Injury Severity Score (ISS), and associated head and facial injuries were recorded. These were analyzed using univariate and multivariate techniques to summarize the association of different variables with TON., Results: During the study period, 0.4% of all trauma patients had TON. The respective demographics for TON group were as follows: male, 76%; median for age, 33.5 years; length of hospital stay, 14 days; ISS, 32; and case fatality, 14%. About two thirds of patients with TON had associated significant head injuries. Conversely, 2.3% of patients with head injury had TON. The relative incidence of TON per year has remained variable from 0% to 1.2%. Motorized vehicle accidents remained the main etiology of TON (63%), but fall had the highest relative frequency leading to TON. In univariate analysis, both ISS and significant head injury were associated with TON. In multivariate analysis, TON was associated with only nasoethmoid complex fractures and significant head injury., Conclusions: These data provide useful information on the frequency and etiologies of TON. It also highlights the importance of studies on better diagnostic tools for TON.
- Published
- 2012
- Full Text
- View/download PDF
44. The epidemiological trends of head injury in the largest Canadian adult trauma center from 1986 to 2007.
- Author
-
Cadotte DW, Vachhrajani S, and Pirouzmand F
- Subjects
- Accidents, Traffic statistics & numerical data, Accidents, Traffic trends, Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Canada epidemiology, Child, Female, Humans, Injury Severity Score, Length of Stay statistics & numerical data, Length of Stay trends, Male, Middle Aged, Prospective Studies, Craniocerebral Trauma epidemiology, Trauma Centers trends
- Abstract
Object: This study documents the epidemiology of head injury over the course of 22 years in the largest Level I adult trauma center in Canada. This information defines the current state, changing pattern, and relative distribution of demographic factors in a defined group of trauma patients. It will aid in hypothesis generation to direct etiological research, administrative resource allocation, and preventative strategies., Methods: Data on all the trauma patients treated at Sunnybrook Health Sciences Centre (SHSC) from 1986 to 2007 were collected in a consecutive, prospective fashion. The authors reviewed these data from the Sunnybrook Trauma Registry Database in a retrospective fashion. The aggregate data on head injury included demographic data, cause of injury, and Injury Severity Score (ISS). The collected data were analyzed using univariate techniques to depict the trend of variables over years. The authors used the length of stay (LOS) and number of deaths per year (case fatality rate) as crude measures of outcome., Results: A total of 16,678 patients were treated through the Level I trauma center at SHSC from January 1986 to December 2007. Of these, 9315 patients met the inclusion criteria (ISS > 12, head Abbreviated Injury Scale score > 0). The median age of all trauma patients was 36 years, and 69.6% were male. The median ISS of the head-injury patients was 27. The median age of this group of patients increased by 12 years over the study period. Motorized vehicle accidents accounted for the greatest number of head injuries (60.3%) although the relative percentage decreased over the study period. The median transfer time of patients sustaining a head injury was 2.58 hours, and there was an approximately 45 minute improvement over the 22-year study period. The median LOS in our center decreased from 19 to 10 days over the study period. The average case fatality rate was 17.4% over the study period. In multivariate analysis, more severe injuries were associated with increased LOS as was increasing time from injury to hospital presentation. Age and injury severity were independently predictive of mortality., Conclusions: These data will provide useful information to guide future studies on the changing patterns of head injury, possible mechanisms of injury, and efficient resource allocation for management of this condition.
- Published
- 2011
- Full Text
- View/download PDF
45. Preoperative stereotactic body radiotherapy to a skull renal cell metastasis: an alternative to preoperative embolization?
- Author
-
Mitera G, Bjarnason GA, Pirouzmand F, Bilbao J, Danjoux C, and Sahgal A
- Subjects
- Carcinoma, Renal Cell surgery, Female, Humans, Intraoperative Complications prevention & control, Kidney Neoplasms surgery, Middle Aged, Preoperative Care methods, Radiation Dosage, Radiography, Carcinoma, Renal Cell diagnostic imaging, Carcinoma, Renal Cell secondary, Embolization, Therapeutic, Kidney pathology, Kidney Neoplasms radiotherapy, Kidney Neoplasms secondary, Radiosurgery, Skull Neoplasms pathology
- Abstract
Introduction: This is the first case study to report on using stereotactic body radiotherapy as an alternative and novel treatment modality for embolization to reduce the risk of operative bleeding for a metastatic renal cell tumor., Case Presentation: A 58-year-old woman presented with an asymptomatic large 7-cm tumor on the parieto-occipital vertex of the skull. Given the location of this lesion along with its vascular histology, it was a challenge to provide safe and effective treatment using conventional management strategies., Conclusion: We report on a rare presentation of a metastatic renal cell cancer and the use of stereotactic body radiotherapy as an innovative radiation approach to deliver high-dose radiation safely to control this large aggressive and vascular metastasis. The success of this management strategy allowed for minimal intraoperative blood loss, and the patient continues with local control 1-year posttreatment.
- Published
- 2011
- Full Text
- View/download PDF
46. Aspergillosis of the Petrous Apex and Meckel's Cave.
- Author
-
Ederies A, Chen J, Aviv RI, Pirouzmand F, Bilbao JM, Thompson AL, and Symons SP
- Abstract
Cranial cerebral aspergillosis is a rare entity in immunocompetent patients. Invasive disease involving the petrous apex and Meckel's cave has rarely been described. We present a case of localized invasive petrous apical and Meckel's cave disease in an immunocompetent patient who presented with hemicranial neuralgic pain.
- Published
- 2010
- Full Text
- View/download PDF
47. Thoracic myelopathy from coincident fluorosis and epidural lipomatosis.
- Author
-
Kalia LV, Lee L, Kalia SK, Pirouzmand F, Rapoport MJ, Aviv RI, Mozeg D, and Symons SP
- Subjects
- Fluoride Poisoning blood, Fluorides blood, Humans, Lipomatosis surgery, Magnetic Resonance Imaging methods, Male, Middle Aged, Spinal Cord Diseases surgery, Tomography, X-Ray Computed methods, Fluoride Poisoning complications, Lipomatosis complications, Spinal Cord Diseases etiology
- Published
- 2010
- Full Text
- View/download PDF
48. Epidemiological trends of spine and spinal cord injuries in the largest Canadian adult trauma center from 1986 to 2006.
- Author
-
Pirouzmand F
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Canada epidemiology, Craniocerebral Trauma epidemiology, Craniocerebral Trauma etiology, Craniocerebral Trauma mortality, Databases, Factual, Female, Humans, Incidence, Male, Middle Aged, Prospective Studies, Registries, Retrospective Studies, Spinal Cord Injuries etiology, Spinal Cord Injuries mortality, Spinal Injuries etiology, Spinal Injuries mortality, Time Factors, Trauma Centers statistics & numerical data, Trauma Centers trends, Trauma Severity Indices, Young Adult, Spinal Cord Injuries epidemiology, Spinal Injuries epidemiology
- Abstract
Object: In this study the author documents the epidemiology of spine and spinal cord injuries (SCIs) over 2 decades at the largest Level I adult trauma center in Canada. He describes the current state of spine injuries (SIs), their changing patterns over the years, and the relative distribution of different demographic factors in a defined group of trauma patients., Methods: Data on all trauma patients admitted to Sunnybrook Health Sciences Centre between 1986 and 2006 were collected from the Sunnybrook Trauma Registry Database. Aggregate data on SIs and SCIs, including demographic information, etiology, severity of injuries (injury severity score [ISS]), and associated injuries, were recorded. The data were analyzed in a main category of spinal fracture and/or dislocation with or without SI and in two subgroups of patients with SIs, one encompassing all forms of SCIs and the other including only complete SCIs (CSCIs). Collected data were evaluated using univariate techniques to depict the trend of variables over the years. The number of deaths per year and the length of stay (LOS) were used as crude measures of outcome. Several multivariate analysis techniques, including Poisson regression, were used to model the frequency of death and LOS as functions of various trauma variables., Results: There were 12,192 trauma patients in the study period with 23.2% having SIs, 5.4% having SCIs, and 3% having CSCIs. The SCIs constituted 23.3% of all SIs. The respective characteristics of the SI, SCI, and CSCI groups were as follows: median age 36, 33, and 30 years; median LOS 18, 27, and 29 days; median ISS 29, 30, and 34; female sex ratio 34, 24, and 23%; and case fatality rate 16.7, 16.6, and 21%. Seventy-nine percent of patients had associated head injuries; conversely, 24% of patients with head injuries had SIs. The mean admission age of patients increased by approximately 10 years over the study period, from the early 30s to the early 40s. The relative incidence of SIs remained stable at approximately 23%, but the incidence of SCIs decreased approximately 40% over time to 4.5%. Motor vehicle accidents remained the principal etiology of trauma, although falling and violence became more frequent contributors of SIs. The average annual ISS remained stable over time, but the LOS was reduced by 50% in both the SI and SCI groups. Age, ISS, and SCIs were associated with a longer LOS. The case fatality rate remained relatively unchanged over time. Poisson analysis suggested that the presence of an SCI does not change the case fatality rate., Conclusions: Data in this analysis will provide useful information to guide future studies on changing SI patterns, possible etiologies, and efficient resource allocation for the management of these diseases.
- Published
- 2010
- Full Text
- View/download PDF
49. Neurosurgical rescue of bradycardia induced by intracerebral hypertension: a case report and review of the literature.
- Author
-
Bedi H, Mitera G, Sahgal A, Pirouzmand F, Bilbao J, Sinclair E, Fitch A, and Chow E
- Subjects
- Adult, Bradycardia etiology, Bradycardia physiopathology, Breast Neoplasms, Female, Humans, Intracranial Hypertension physiopathology, Review Literature as Topic, Bradycardia surgery, Brain Edema complications, Intracranial Hypertension complications, Neurosurgical Procedures
- Abstract
Brain metastases usually occur secondary to lung, breast, unknown primary, melanoma, and colon cancers. A growing tumor in the brain is commonly associated with edema and increased intracranial pressure (ICP). Common signs and symptoms due to increased ICP or brain edema include headache, nausea, and vomiting. One of the main treatment modalities in the management of brain metastases is whole-brain radiation. However, increased ICP may lead to acute deterioration of the neurologic status due to development of radiation-induced edema. Therefore, alternative management options should be considered for these patients to avoid complications from whole-brain radiation treatment. We discuss the case of a brain metastases patient who presented with bradycardia induced by brain edema.
- Published
- 2009
- Full Text
- View/download PDF
50. Vascularized mastoid bone flap cranioplasty after translabyrinthine vestibular schwannoma surgery.
- Author
-
Yuen HW, Thompson AL, Symons SP, Pirouzmand F, and Chen JM
- Abstract
Objective: We describe a novel technique of cranioplasty using a vascularized mastoid bone flap in patients after translabyrinthine excision of vestibular schwannomas (VS). Postoperative outcomes in terms of pinna and postauricular deformity are evaluated., Study Design: Retrospective study., Setting: Tertiary referral center., Results: Seventeen patients underwent cranioplasty with bone flap after translabyrinthine VS excision. At minimum follow-up of 12 months, none had a cerebrospinal fluid (CSF) leak. The measured pinna projections between the operated and non-operated sides had a mean difference of 0.80 mm (+/-1.70), which is not statistically significant (p > 0.05). The mean depth of the postauricular depressions was 1.38 mm (+/-0.93). Over the same period, 10 patients underwent translabyrinthine VS surgery without cranioplasty. In this group, there was a significant difference of 4.71 mm (+/-1.53) in mean pinna underprojections on the operated sides compared with the non-operated sides. Compared with patients who have undergone cranioplasty, the retroauricular depressions were significantly deeper (p < 0.05) with a mean depth of 2.92 mm (+/-1.21)., Conclusions: Vascularized mastoid cortical bone flap cranioplasty is a simple and effective technique to ameliorate the pinna and retroauricular deformities after translabyrinthine VS excision without increased surgical cost or the use of alloplastic materials.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.